Cyromazine Market

Cyromazine Market - Size, Share, Outlook, and
Opportunity Analysis, 2018 – 2026
Cyromazine is an insect growth regulator (IGR) and is a cyclopropyl & an aminotriazine
derivative of melamine. Cyromazine finds application in animal healthcare and agriculture.
Cyromazine and other IGRs interfere with the life cycle of insects by acting on the hormonal
control of development. IGRs interfere with normal progress and growth of the insect,
resulting in an insect’s mortality before it reaches adulthood.
Among applications, crop protection segment accounted for the largest revenue share of
78.4% in the global cyromazine market in 2017. There is high demand for insect growth
regulators such as cyromazine in the agriculture industry, to protect crops from insects and
thereby improve agriculture production. According to the statistical data of Food and
Agriculture Organization (FAO), insecticide use was around 60.6 thousand tons by Brazil
alone in 2016.
Request For Sample Copy of this Research Report :
Among regions, North America held significant market share in the global cyromazine
market in 2017, owing to increasing household income of the populace in the region, which
in turn increases buying power and thus the demand for food. According to Peter G. Peterson
Foundation’s news published in September 2018, the median household income of the U.S.
increased from US$ 60,309 in 2016 to US$ 61,372 in 2017. Rising income levels in the U.S.
is boosting demand for agriculture and food products. Therefore, increasing demand for food
will pose a need to maximize agriculture output and usage of insect growth regulators in the
agriculture sector. This in turn is expected to be a key driver for growth of the cyromazine
market over the forecast period.
However, the slow-acting impact of cyromazine and availability of substitutes to cyromazine
such as methoprene are expected to restrain the market growth. Furthermore, the
development of resistance towards insect growth regulators is expected to be one of the major
challenges restraining the market growth.
The global cyromazine market was valued at US$ 1.27 million in 2017 and is expected to
register a CAGR of 6.03% in terms of revenue over the forecast period (2019 – 2026), to
reach US$ 2.18 million by 2026.
Asia Pacific is the fastest growing region and accounted for the largest market share of 37.2%
in 2017, owing to growing agricultural industry in economies such as India in this region.
According to India Brand Equity Foundation report on Agriculture and Allied Industries
published in May 2018, food grain production was 279.51 million tons in India during crop
year of 2017-2018. The report also states that there is a rising demand for Indian food and
agricultural products in the international market. The total agricultural exports from India
witnessed a CAGR of 16.45% over FY10-18 to reach US$ 38.21 billion in FY18. In April
2018, agriculture exports was US$ 3.15 billion. Therefore, growth of agricultural industry is
expected to increase crop protection solutions, which in turn is expected to propel demand for
cyromazine insecticides.
Players operating in the global cyromazine market are adopting various growth strategies to
cater to increasing demand for cyromazine. For instance, in December 2017, ADAMA and
ALRISE Biosystems signed an R&D agreement, in order to develop highly effective and
sustainable crop protection products for farmers with a lower dose of active ingredients.
Major players operating in the global cyromazine market include Syngenta AG, ADAMA
Agricultural Solutions Ltd., Elanco Animal Health Inc., Jurox Pty Limited., Arysta
LifeScience Corporation, Lasa Supergenerics Limited, Orion AgriScience Limited, Topsen
Biotech Co. Ltd., Shandong Luxi Animal Medicine Share Co., Ltd., Bayer AG, and Toronto
Research Chemicals Inc.
For More Information:
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting services, and
competitive analysis through various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Tel: +1-206-701-6702
Email​: [email protected]

The global cyromazine market was valued at US$ 1.27 million in 2017 and is expected to register a CAGR of 6.03% in terms of revenue over the forecast period (2019 – 2026), to reach US$ 2.18 million by 2026.